Treating wasting disorders with selective androgen receptor modulators
US7855229B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2005 |
| Grant date | Dec 21, 2010 |
| Priority date | — |
| Expiry date | Apr 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/277
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides: 1) a method of treating a subject suffering from a muscle wasting disorder; 2) a method of preventing a muscle wasting disorder in a subject; 3) a method of treating, preventing, suppressing, inhibiting or reducing muscle loss in a subject suffering from a muscle wasting disorder; 4) a method of treating, preventing, inhibiting, reducing or suppressing muscle wasting in a subject suffering from a muscle wasting disorder; and/or 5) a method of treating, preventing, inhibiting, reducing or suppressing muscle protein catabolism in a subject suffering from a muscle wasting disorder, by administering to the subject a selective androgen receptor modulator (SARM) and/or an analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, impurity or crystal of said SARM compound, or any combination thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.